Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China · Delayed Price · Currency is CNY 63.10
+0.38 (0.61%)
Mar 27, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 4.91 billion as of March 27, 2026. Its market cap has decreased by -20.01% in one year.
Market Cap
4.91B
Enterprise Value
2.46B
Revenue
911.30M
Ranking
n/a
PE Ratio
22.81
Stock Price
63.10
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 4.91B, a decrease of -47.62%. That is a compound annual growth rate of -12.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 4.91B | -1.83% |
| Dec 31, 2025 | 5.00B | 1.91% |
| Dec 31, 2024 | 4.91B | -8.43% |
| Dec 29, 2023 | 5.36B | -2.86% |
| Dec 30, 2022 | 5.52B | -16.76% |
| Dec 31, 2021 | 6.63B | -29.28% |
| Mar 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hubei Huaqiang High-Tech | 6.53B |
| Mingyue Optical Lens | 6.42B |
| Zhonghong Pulin Medical Products | 5.81B |
| BMC Medical | 5.72B |
| QITIAN Technology Group | 5.55B |
| Jiangxi Sanxin Medtec | 4.60B |
| SWS Hemodialysis Care | 4.58B |
| Chimin Health Management | 4.47B |